Cancer

1. ROSENBERG SM, McCue S, He J, Lafky JM, et al
   Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
   Cancer. 2024;130:750-769.
   

   >> Share

   
   

   
   J Am Acad Dermatol

2. HUANG Y, Fleming P, Fung K, Chan AW, et al
   Association between dermatology follow-up and melanoma survival: a population-based cohort study.
   J Am Acad Dermatol. 2024 Feb 16:S0190-9622(24)00372.
   

   >> Share

   
   

   
   J Clin Oncol

3. DE VIS JB, Cmelak AJ, Osmundson EC
   Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy?
   J Clin Oncol. 2023 Dec 11:JCO2302151. doi: 10.1200/JCO.23.02151.
   

   >> Share

   
   

   
   J Invest Dermatol

4. LIOPYRIS K, Navarrete-Dechent C, Marchetti MA, Rotemberg V, et al
   Expert agreement on the presence and spatial localization of melanocytic features in dermoscopy.
   J Invest Dermatol. 2023 Sep 7:S0022-202X(23)02577.
   

   >> Share

   
   

   
   Melanoma Res

5. DE PINTO G, Mignozzi S, La Vecchia C, Levi F, et al
   Global trends in cutaneous malignant melanoma incidence and mortality.
   Melanoma Res. 2024 Feb 21. doi: 10.1097/CMR.0000000000000959.
   

   >> Share

   
   

   
   Nat Med

6. BJORK JR, Bolte LA, Maltez Thomas A, Lee KA, et al
   Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
   Nat Med. 2024 Feb 16. doi: 10.1038/s41591-024-02803.
   

   >> Share

   
   

   
   Oncogene

7. JESSEN M, Gertzmann D, Liss F, Zenk F, et al
   Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.
   Oncogene. 2024;43:578-593.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share